Rhinitis, sinusitis, and upper airway diseaseProtein disulfide isomerase–endoplasmic reticulum resident protein 57 regulates allergen-induced airways inflammation, fibrosis, and hyperresponsiveness
Section snippets
Human samples
Lung tissues from patients with physician-diagnosed asthma and nonasthmatic subjects were obtained from the Department of Medicine of the University of California, San Francisco (UCSF), and the Department of Pathobiology of the Cleveland Clinic. The Institutional Review Boards of the University of California and Cleveland Clinic approved provision of deidentified materials for research at the University of Vermont. All subjects were nonsmokers defined as never smokers or former smokers with no
ERp57 levels are increased in human subjects with asthma and mice with allergic airways disease
To investigate whether ERp57 expression is altered in the lung during asthma pathogenesis, we stained bronchial biopsy samples from nonasthmatic and asthmatic subjects (who refrained from inhaled corticosteroids for 6 weeks before the study) for ERp57 by means of immunohistochemistry. Marked increases in ERp57 levels were observed in lung samples from asthmatic patients (n = 9) compared with nonasthmatic subjects (n = 9; Fig 1, A, and see Fig E1, A and C, and Table E1, Table E2 in this
Discussion
Our results show that asthmatic patients exhibit a marked increase in ERp57 levels compared with those in nonasthmatic subjects, predominantly in the lung epithelium. Using a murine model of allergic asthma, we demonstrated that epithelium-specific upregulation of PDI-ERp57 modulates allergen-induced inflammation, AHR, and airways fibrosis in the lung. Furthermore, we also report that adaptive immune responses are dispensable for the development of allergen-induced UPR, upregulation of ERp57,
References (48)
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
Lancet
(2008)- et al.
Orchestrating house dust mite-associated allergy in the lung
Trends Immunol
(2011) - et al.
Allergen-specific IgE levels and mite allergen exposure in children with acute asthma first seen in an emergency department and in nonasthmatic control subjects
J Allergy Clin Immunol
(1996) - et al.
Distinct TLR-mediated pathways regulate house dust mite-induced allergic disease in the upper and lower airways
J Allergy Clin Immunol
(2013) - et al.
Role of protease-activated receptors in airway function: a target for therapeutic intervention?
Pharmacol Ther
(2002) - et al.
The ER stress transducer IRE1beta is required for airway epithelial mucin production
Mucosal Immunol
(2013) - et al.
Proapoptotic activities of protein disulfide isomerase (PDI) and PDIA3 protein, a role of the Bcl-2 protein Bak
J Biol Chem
(2015) - et al.
Periostin is required for maximal airways inflammation and hyperresponsiveness in mice
J Allergy Clin Immunol
(2014) - et al.
Innate immune responses of airway epithelium to house dust mite are mediated through beta-glucan-dependent pathways
J Allergy Clin Immunol
(2009) - et al.
Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors
Free Radic Biol Med
(2006)
Epithelial-mesenchymal interactions in the pathogenesis of asthma
J Allergy Clin Immunol
A sigma-1 receptor antagonist (NE-100) prevents tunicamycin-induced cell death via GRP78 induction in hippocampal cells
Biochem Biophys Res Commun
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
J Allergy Clin Immunol
The airway epithelium in asthma
Nat Med
The role of airway epithelial cells and innate immune cells in chronic respiratory disease
Nat Rev Immunol
House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells
Nat Med
Airway epithelial cells regulate the functional phenotype of locally differentiating dendritic cells: implications for the pathogenesis of infectious and allergic airway disease
J Immunol
Airway epithelial NF-kappaB activation promotes allergic sensitization to an innocuous inhaled antigen
Am J Respir Cell Mol Biol
Endoplasmic reticulum stress mediates house dust mite-induced airway epithelial apoptosis and fibrosis
Respir Res
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress
Nat Cell Biol
The unfolded protein response: controlling cell fate decisions under ER stress and beyond
Nat Rev Mol Cell Biol
From endoplasmic-reticulum stress to the inflammatory response
Nature
Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins
Nat Chem Biol
AGR2 is induced in asthma and promotes allergen-induced mucin overproduction
Am J Respir Cell Mol Biol
Cited by (0)
Supported by National Institutes of Health (NIH) grant R01HL122383, a Parker B. Francis Fellowship, and American Thoracic Society unrestricted grant, the AAFA-Sheldon C. Siegel award, the UVM-College of Medicine Internal Grant Program to V.A. and NIH grant R01HL079331 to Y.M.W.J.-H. D.G.C. is a recipient of a CJ Martin Fellowship from the national Health and Medical Research Council of Australia (1053790). S.C.E. and S.A.A.C. are supported by NIH grants HL103453 and HL081064.
Disclosure of potential conflict of interest: S. M. Hoffman has received a grant from the National Institutes of Health (NIH). G. K. Rattu has received a Summer Research Award from the University of Vermont and received payment for research from that award. K. A. Fortner has received grants from the NIH and is employed by the University of Vermont. S. C. Erzurum has received grants from the NIH, is the chair of the American Board of Internal Medicine Pulmonary Disease Board, and has received honoraria as Councilor for the Association of American Physicians. P. G. Woodruff has received grants from Genentech and the NIH; has received personal fees from Genentech, Johnson and Johnson, Roche, Neostem, Astra Zeneca, and Novartis; and has a patent pending for 12/935822 “Compositions and methods for treating and diagnosing asthma.” N. Bhakta has received grants from Genentech. A. E. Dixon has consultant arrangements with Roche and has received grants from the NIH and Pfizer. C. G. Irvin has received a grant from the NIH. Y. M. W. Janssen-Heininger has received a grant from the NIH (HLR01079331). M. E. Poynter has received grants from NIH, the Asthma and Allergy Foundation of America, and the Flight Attendant Medical Research Institute. V. Anathy has received grants from the NIH (R01HL122383), the Parker B. Francis Foundation, the American Thoracic Society, and the Asthma and Allergy Foundation of America; has received travel support from the Parker B. Francis Foundation; and is employed by the University of Vermont. The rest of the authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally to this work.